Cargando…

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update

Positron emission tomography/computed tomography (PET/CT) integrated with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) is a useful tool for acquisition of both glucose metabolism and anatomic imaging data, as only a single device and one diagnostic session is required, thus opening a new field in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitajima, Kazuhiro, Nakajo, Masatoyo, Kaida, Hayato, Minamimoto, Ryogo, Hirata, Kenji, Tsurusaki, Masakatsu, Doi, Hiroshi, Ueno, Yoshiko, Sofue, Keitaro, Tamaki, Yukihisa, Yamakado, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nagoya University 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719212/ https://www.ncbi.nlm.nih.gov/pubmed/29238109 http://dx.doi.org/10.18999/nagjms.79.4.527

Ejemplares similares

Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer
por: Kawanaka, Yusuke, et al.
Publicado: (2018)

Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT
por: Minamimoto, Ryogo
Publicado: (2021)

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

FDG-PET/CT finding of benign metastasizing leiomyoma of the lung
por: Nakajo, Masatoyo, et al.
Publicado: (2012)

Diagnostic performance of zero-TE lung MR imaging in FDG PET/MRI for pulmonary malignancies
por: Zeng, Feibi, et al.
Publicado: (2020)

Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma
por: Tsujita, Yushi, et al.
Publicado: (2023)

Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review
por: Minamimoto, Ryogo
Publicado: (2022)

Improved diagnosis of histological capsule in hepatocallular carcinoma by using nonenhancing capsule appearance in addition to enhancing capsule appearance in gadoxetic acid-enhanced MRI
por: Nishioka, Eiko, et al.
Publicado: (2023)

Role of Diffusion Weighted Imaging and Contrast-Enhanced MRI in the Evaluation of Intrapelvic Recurrence of Gynecological Malignant Tumor
por: Kitajima, Kazuhiro, et al.
Publicado: (2015)

Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Kitajima, Kazuhiro, et al.
Publicado: (2019)

Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
por: Toyama, Yoshitaka, et al.
Publicado: (2020)

Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using (18)F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Deep learning with deep convolutional neural network using FDG-PET/CT for malignant pleural mesothelioma diagnosis
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Physiological skin FDG uptake: A quantitative and regional distribution assessment using PET/MRI
por: Nogami, Munenobu, et al.
Publicado: (2021)

Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2019)

Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey
por: Minamimoto, Ryogo, et al.
Publicado: (2014)

Proliferation PET/CT Imaging of Salivary Gland Tumor
por: Minamimoto, Ryogo
Publicado: (2021)

Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma
por: Minamimoto, Ryogo, et al.
Publicado: (2016)

Cell Proliferation PET Imaging with 4DST PET/CT in Colorectal Adenocarcinoma and Adenoma
por: Minamimoto, Ryogo, et al.
Publicado: (2021)

Usefulness of semi-automatic harmonization strategy of standardized uptake values for multicenter PET studies
por: Daisaki, Hiromitsu, et al.
Publicado: (2021)

Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Diagnostic performance of (18)F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI
por: Hotta, Masatoshi, et al.
Publicado: (2018)

Quantitative FDG PET Assessment for Oncology Therapy
por: Hirata, Kenji, et al.
Publicado: (2021)

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Dual-Energy Computed Tomography of the Liver: Uses in Clinical Practices and Applications
por: Tsurusaki, Masakatsu, et al.
Publicado: (2021)

Plug-assisted Retrograde Transvenous Obliteration-II for Gastric Varices: A Case Report
por: Tsurusaki, Masakatsu, et al.
Publicado: (2023)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy
por: Nakaigawa, Noboru, et al.
Publicado: (2017)

Magnetic resonance imaging of intraocular optic nerve disorders: review article
por: Kanda, Tomonori, et al.
Publicado: (2020)

Imaging patients with breast and prostate cancers using combined 18F NaF/18F FDG and TOF simultaneous PET/ MRI
por: Iagaru, Andrei, et al.
Publicado: (2015)

Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with (18)F-FDG contrast-enhanced PET/CT and pelvic MRI
por: Kitajima, Kazuhiro, et al.
Publicado: (2013)

Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in (18)F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy
por: Higuchi, Tomoko, et al.
Publicado: (2019)

The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma
por: Kaida, Hayato, et al.
Publicado: (2022)

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma
por: Nakaigawa, Noboru, et al.
Publicado: (2016)

Value of Patlak Ki images from (18)F-FDG-PET/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis
por: Nakajo, Masatoyo, et al.
Publicado: (2021)

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
por: Kakizoe, Manabu, et al.
Publicado: (2014)

(11)C-Choline positive but (18)F-FDG negative pancreatic metastasis from renal cell carcinoma on PET
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

(18)F-FDG and (11)C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective study
por: Minamimoto, Ryogo, et al.
Publicado: (2019)

11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier
por: Hotta, Masatoshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j3u088g9qeb25cndcude0cipeh